Seeking Alpha

Vermillion (VRML +54.1%) shares soar after the molecular diagnostics company says it received...

Vermillion (VRML +54.1%) shares soar after the molecular diagnostics company says it received Category 1 CPT Code approval for OVA1 test designed to help differentiate benign vs. malignant ovarian masses. VRML also says it received a notice of allowance from the U.S. Patent and Trademark Office for a patent for "platelet biomarkers for cancer."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)